ArticleApplied microbiology and biotechnology2026
Identification of targets for high penicillin G production in an industrial strain of Penicillium rubens.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To elucidate the mechanisms underlying high penicillin G (PenG) production, transcriptomic analysis was conducted on 36 samples from the reference Penicillium rubens Wisconsin 54-1255 and its industrial descendant strain IMP002. The resulting dataset was analyzed using weighted gene co-expression network analysis, yielding 26 modules that clustered genes with similar expression patterns. Three modules highly correlated with PenG production were selected to identify key hub genes, whose functions were further validated in vivo. Overexpression of the six identified hub genes, comprising one transporter gene, four regulatory genes, and one N-acetylglucosaminyltransferase gene, increased PenG production in IMP002 by 24.08% to 41.64%. Notably, overexpression of the transporter gene led to a 33.33% increase in intracellular PenG accumulation. Moreover, overexpression of the N-acetylglucosaminyltransferase gene was found to modulate the filamentation of IMP002. Our work provides an effective strategy for identifying novel targets related to high PenG production in the industrial strain. KEY POINTS: Six key targets for high PenG production were identified in the strain IMP002. Regulator, transporter, and N-acetylglucosaminyltransferase boost PenG production. WGCNA is an effective strategy for identifying novel high-yield targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.